Influenza A viruses have the potential for zoonotic transmission, where the virus jumps from animals to humans, leading to novel and potentially pandemic strains. Certain subtypes, such as H5N1 and H7N9, have caused outbreaks in poultry and sporadic human cases, raising concerns about their pandemic potential. Notable historical examples include the 1918 Spanish flu caused by an H1N1 strain and the 2009 H1N1 influenza pandemic. Zoonotic transmission often occurs at the human-animal interface, particularly in live bird markets and intensive farming settings. The genetic reassortment ability of influenza A allows for the creation of viruses with pandemic potential, as seen in the H1N1 pandemic of 2009, which resulted from a reassortment involving human, avian, and swine influenza viruses. Pandemic preparedness involves global collaboration, surveillance, and research to monitor high-risk areas for potential outbreaks. The development of rapid diagnostics, antiviral medications, and vaccines that provide broader protection against diverse influenza A strains is a critical aspect of pandemic preparedness. International initiatives, such as the Global Influenza Surveillance and Response System (GISRS), facilitate information sharing and coordinated responses to potential pandemics.